PINC Research has come out with its report on pharma sector. According to the research firm Cipla has applied for voluntary licenses for Raltegravir (ARV drug) to Merck while Natco has also applied for Maraviroc (ARV drug) to Pfizer/Glaxo.
Natco Pharma (Natco) has won the Compulsory License (CL) to manufacture and sell generic version of BayerDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
